{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:40:32Z","timestamp":1793299232197,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T00:00:00Z","timestamp":1384992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","respiratoryinvestigation.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.resinv.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T21:04:54Z","timestamp":1382994294000},"page":"260-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":257,"title":["Consensus statement for the diagnosis and treatment of drug-induced lung injuries"],"prefix":"10.1016","volume":"51","author":[{"given":"Keishi","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Genma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumikazu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2013.09.001_bib1","unstructured":"ICH harmonised tripartite guideline; clinical safety data management: definitions and standards for expedited reporting. [Internet]. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH); 1994 October 27. Available from: \u3008http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2A\/Step4\/E2A_Guideline.pdf\u3009."},{"issue":"5","key":"10.1016\/j.resinv.2013.09.001_bib2","first-page":"405","article-title":"High prevalence of drug-induced pneumonia in Japan","volume":"50","author":"Azuma","year":"2007","journal-title":"Jpn Med Assoc J"},{"key":"10.1016\/j.resinv.2013.09.001_bib3","unstructured":"Pharmaceuticals and medical devices safety information [Internet]. Tokyo: Ministry of Health, Labour and Welfare. Available from: \u3008http:\/\/www1.mhlw.go.jp\/kinkyu\/iyaku_j\/iyaku_j\/anzenseijyouhou.html\u3009 [Japanese]."},{"issue":"9352","key":"10.1016\/j.resinv.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(03)12190-3","article-title":"Severe acute interstitial pneumonia and gefitinib","volume":"361","author":"Inoue","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2013.09.001_bib5","unstructured":"Pharmaceuticals and Medical Devices Information Website [Internet]. Tokyo: Pharmaceuticals and Medical Devices Agency, Japan. Available from: \u3008http:\/\/www.info.pmda.go.jp\/\u3009 [Japanese]."},{"issue":"12","key":"10.1016\/j.resinv.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/rccm.200710-1501OC","article-title":"Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study","volume":"177","author":"Kudoh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.resinv.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1164\/ajrccm.177.12.1397a","article-title":"Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients","volume":"177","author":"Azuma","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.resinv.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.resinv.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/187153006779025775","article-title":"Recent advances in the treatment of interstitial lung disease in patients with polymyositis\/dermatomyositis","volume":"6","author":"Kameda","year":"2006","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.resinv.2013.09.001_bib10","unstructured":"AstraZeneca KK. The final report of the specialist committee on acute lung injury\/interstitial pneumonia induced by gefitinib (Iressa\u00ae tablets 250); 2003 [Japanese]."},{"key":"10.1016\/j.resinv.2013.09.001_bib11","unstructured":"Mukai H, et al. 72nd Annual Meeting of the Japanese Society of Hematology; 2010."},{"key":"10.1016\/j.resinv.2013.09.001_bib12","unstructured":"U.S. Food and Drug Administration. Prescribing information for Tarceva; 2009."},{"issue":"4","key":"10.1016\/j.resinv.2013.09.001_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"Camus","year":"2004","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.resinv.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","article-title":"KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease","volume":"148","author":"Kohno","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"10","key":"10.1016\/j.resinv.2013.09.001_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/thorax.58.10.872","article-title":"Circulating KL-6 levels in patients with drug induced pneumonitis","volume":"58","author":"Ohnishi","year":"2003","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.resinv.2013.09.001_bib16","first-page":"33","article-title":"Drug-induced pneumonitis","volume":"74","author":"Kondo","year":"1999","journal-title":"Kekkaku"},{"issue":"4","key":"10.1016\/j.resinv.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/crad.2001.0792","article-title":"Drug-induced lung disease: high-resolution CT and histological findings","volume":"57","author":"Cleverley","year":"2002","journal-title":"Clin Radiol"},{"key":"10.1016\/j.resinv.2013.09.001_bib18","first-page":"540","article-title":"Clinical characteristics of drug-induced lung diseases, including bronchiolitis obliterans associated with consumption of Sauropus androgynus","volume":"23","author":"Oonakahara","year":"2004","journal-title":"Kokyu"},{"issue":"1","key":"10.1016\/j.resinv.2013.09.001_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0272-5231(03)00143-6","article-title":"Bronchoalveolar lavage in drug-induced lung disease","volume":"25","author":"Costabel","year":"2004","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.resinv.2013.09.001_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0272-5231(03)00128-X","article-title":"Drug-induced pulmonary edema and acute respiratory distress syndrome","volume":"25","author":"Lee-Chiong","year":"2004","journal-title":"Clin Chest Med"},{"issue":"3 Pt 1","key":"10.1016\/j.resinv.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American\u2013European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.resinv.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2169\/internalmedicine.41.953","article-title":"Systemic capillary leak syndrome","volume":"41","author":"Chihara","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2013.09.001_bib23","first-page":"2225","article-title":"Drug-induced respiratory dysfunction: pulmonary edema","volume":"31","author":"Tatsukawa","year":"1995","journal-title":"Iyaku J"},{"issue":"2","key":"10.1016\/j.resinv.2013.09.001_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1634\/theoncologist.6-2-153","article-title":"Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy","volume":"6","author":"Briasoulis","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.resinv.2013.09.001_bib25","series-title":"Drug-Induced Respiratory Dysfunction","first-page":"44","article-title":"4. Drug-induced vascular lesions; 4. Drug-induced pulmonary edema","author":"Ishikawa","year":"2005"},{"issue":"9","key":"10.1016\/j.resinv.2013.09.001_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJM198908313210903","article-title":"Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure","volume":"321","author":"Allen","year":"1989","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.resinv.2013.09.001_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0272-5231(03)00141-2","article-title":"Drug-induced eosinophilic lung disease","volume":"25","author":"Allen","year":"2004","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1016\/j.resinv.2013.09.001_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"Camus","year":"2004","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.resinv.2013.09.001_bib29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2006-939522","article-title":"Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia","volume":"27","author":"Solomon","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"issue":"1 Suppl.","key":"10.1016\/j.resinv.2013.09.001_bib30","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.resinv.2013.09.001_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autrev.2010.07.005","article-title":"Drug-induced lupus: an update","volume":"10","author":"Katz","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.resinv.2013.09.001_bib32","unstructured":"\u3008http:\/\/www.pneumotox.com\u3009. Pneumotox\u00ae Website: Last update 2012-v2."},{"issue":"1","key":"10.1016\/j.resinv.2013.09.001_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-5231(03)00123-0","article-title":"Chemotherapy-induced lung disease","volume":"25","author":"Limper","year":"2004","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.resinv.2013.09.001_bib34","unstructured":"Pharmaceuticals and medical devices safety information no. 206 [Internet]. Tokyo: Ministry of Health, Labour and Welfare; 2004. Available from: \u3008http:\/\/www.mhlw.go.jp\/houdou\/2004\/10\/h1028-2a.html\u3009 [Japanese]."},{"key":"10.1016\/j.resinv.2013.09.001_bib35","unstructured":"Chugai Pharmaceutical Co., Ltd. Tarceva\u00ae specified drug-use survey (all-case surveillance): final analysis report on 3000 cases. 2010 [Japanese]."},{"issue":"2","key":"10.1016\/j.resinv.2013.09.001_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1349-7006.2010.01810.x","article-title":"Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancer","volume":"102","author":"Okusaka","year":"2011","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.resinv.2013.09.001_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/rccm.200911-1720OC","article-title":"Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma","volume":"182","author":"White","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2013.09.001_bib38","unstructured":"Pfizer Japan Inc. TORISEL\u00ae injection 25mg appropriate use guidelines [Japanese]."},{"issue":"13","key":"10.1016\/j.resinv.2013.09.001_bib39","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1200\/JCO.2010.29.2235","article-title":"Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus","volume":"29","author":"Maroto","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.resinv.2013.09.001_bib40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2169\/internalmedicine.47.0702","article-title":"Clinical and radiographical features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study","volume":"47","author":"Tokuda","year":"2008","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.resinv.2013.09.001_bib41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarc\u00f3n","year":"1997","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.resinv.2013.09.001_bib42","first-page":"1164","article-title":"Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature","volume":"14","author":"Searles","year":"1987","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.resinv.2013.09.001_bib43","first-page":"2299","article-title":"Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis","volume":"24","author":"Ohosone","year":"1997","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.resinv.2013.09.001_bib44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/s10165-010-0280-z","article-title":"Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA","volume":"20","author":"Shidara","year":"2010","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.resinv.2013.09.001_bib45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2169\/internalmedicine.50.4508","article-title":"Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study","volume":"50","author":"Kameda","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2013.09.001_bib46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/s10165-007-0626-3","article-title":"Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis","volume":"17","author":"Koike","year":"2007","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.resinv.2013.09.001_bib47","first-page":"391","article-title":"Pneumonitis induced by the herbal medicine Sho-saiko-to in Japan","volume":"35","author":"Sato","year":"1997","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"3","key":"10.1016\/j.resinv.2013.09.001_bib48","first-page":"95","article-title":"Guidelines of Sho-saiko-to\/Xiao-Chaihu-Tang treatment in patients with chronic hepatitis C","volume":"17","author":"Suzuki","year":"2000","journal-title":"Wakan Iyakugaku Zasshi"},{"issue":"1","key":"10.1016\/j.resinv.2013.09.001_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/ajrccm\/146.1.266","article-title":"Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus","volume":"146","author":"Ueda","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"10.1016\/j.resinv.2013.09.001_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.resinv.2013.09.001_bib51","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1253\/circj.71.1610","article-title":"Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone","volume":"71","author":"Yamada","year":"2007","journal-title":"Circ J"},{"issue":"7","key":"10.1016\/j.resinv.2013.09.001_bib52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/11532320-000000000-00000","article-title":"Amiodarone: review of pulmonary effects and toxicity","volume":"33","author":"Papiris","year":"2010","journal-title":"Drug Saf"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253451300124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253451300124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T07:56:46Z","timestamp":1564559806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221253451300124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S221253451300124X"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2013.09.001","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus statement for the diagnosis and treatment of drug-induced lung injuries","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Japanese Respiratory Society. Published by Elsevier Japan KK","name":"copyright","label":"Copyright"}]}}